22 min listen
Dr Benjamin Levy on the Management of Lung Cancer in the COVID-19 Era
Dr Benjamin Levy on the Management of Lung Cancer in the COVID-19 Era
ratings:
Length:
20 minutes
Released:
May 19, 2020
Format:
Podcast episode
Description
Dr Benjamin Levy from Johns Hopkins comments on changes to the surgical and targeted treatment of lung cancer during COVID-19 and challenges in the management of immune-related adverse events with immune checkpoint inhibitors.
RTP Lung Cancer Summit Presentations (https://www.researchtopractice.com/LungCancerSummit20/)
Additional Resources
* Banna G et al. How we treat patients with lung cancer during the SARS-CoV-2 pandemic: primum non nocere. ESMO Open 2020;5(2). Abstract (https://pubmed.ncbi.nlm.nih.gov/32245904/)
Kumar S et al. Alternative multidisciplinary management options for locally advanced non-small cell lung cancer during the COVID-19 global pandemic. J Thorac Oncol 2020;[Online ahead of print]. Abstract (https://pubmed.ncbi.nlm.nih.gov/32360578)
Thoracic Surgery Outcomes Research Network, Inc. COVID-19 guidance for triage of operations for thoracic malignancies: A consensus statement from Thoracic Surgery Outcomes Research Network. Ann Thorac Surg 2020;[Online ahead of print]. Abstract (https://pubmed.ncbi.nlm.nih.gov/32278755)
RTP Lung Cancer Summit Presentations (https://www.researchtopractice.com/LungCancerSummit20/)
Additional Resources
* Banna G et al. How we treat patients with lung cancer during the SARS-CoV-2 pandemic: primum non nocere. ESMO Open 2020;5(2). Abstract (https://pubmed.ncbi.nlm.nih.gov/32245904/)
Kumar S et al. Alternative multidisciplinary management options for locally advanced non-small cell lung cancer during the COVID-19 global pandemic. J Thorac Oncol 2020;[Online ahead of print]. Abstract (https://pubmed.ncbi.nlm.nih.gov/32360578)
Thoracic Surgery Outcomes Research Network, Inc. COVID-19 guidance for triage of operations for thoracic malignancies: A consensus statement from Thoracic Surgery Outcomes Research Network. Ann Thorac Surg 2020;[Online ahead of print]. Abstract (https://pubmed.ncbi.nlm.nih.gov/32278755)
Released:
May 19, 2020
Format:
Podcast episode
Titles in the series (100)
Dr Tom Lynch on Adjuvant EGFR TKIs in Lung Cancer and COVID-19 in Seattle: Dr Tom Lynch comments on the current status of oncology research and data soon to be presented from a Phase III trial evaluating the EGFR TKI osimertinib as adjuvant therapy for patients with non-small cell lung cancer and EGFR tumor mutations. by Oncology Today with Dr Neil Love